Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07214298) titled 'Pegcetacoplan in Combination With Modified FOLFIRINOX for the Treatment of Metastatic Pancreatic Ductal Adenocarcinoma' on Oct. 6.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Roswell Park Cancer Institute
Condition:
Metastatic Pancreatic Ductal Adenocarcinoma
Stage IV Pancreatic Cancer AJCC v8
Intervention:
Procedure: Biopsy Procedure
Procedure: Biospecimen Collection
Procedure: Computed Tomography
Drug: Fluorouracil
Drug: Irinotecan
Drug: Leucovorin Calcium
Procedure: Magnetic Res...